Bryan Garnier

Since 1996, Bryan, Garnier & Co has been growing with an absolute conviction that the investment banking landscape would experience a major revolution: most of the large local generalist banking groups will disappear to the benefit of a handful of global powerhouses, and an emerging group of independent, highly specialised boutique investment banks.

Clement Genelot
  • Clement Genelot

Food for thought on Ahold Delhaize's aborted acquisition talks with Ca...

Ahold Delhaize is said to have approached Carrefour in late 2024 before walking away in January 2025. The failed discussions are positive for us as a deal would have totally transformed Ahold Delhaize's equity story from "defensive/yield" to a tentative and very risky "growth/recovery" with a likel

Mahaut Arnaud ... (+3)
  • Mahaut Arnaud
  • Paul de Froment
  • Thomas Mordelle

Waga Energy: Hartland is live

This morning, together with the Capital Region District (CRD) of Vancouver, Waga Energy announced it has completed the commissioning and therefore started to produce biomethane in Hartland (Canada). The site has been equipped with a Wagabox capable of producing approximately 100GWh/year of biometha

Oscar Haffen Lamm
  • Oscar Haffen Lamm

Cinclus Pharma: partners with Zentiva in a deal worth EUR220m for its ...

Cinclus Pharma entered into a agreement with Zentiva for the EU rights of linaprazan glurate in a total deal value of EUR220m, including an upfront payment of EUR13m and a near-term milestone of EUR5m in 2026, and is entitled to receive tiered double-digit royalties on net sales in Europe, starting

Mahaut Arnaud ... (+3)
  • Mahaut Arnaud
  • Paul de Froment
  • Thomas Mordelle

Avantium: factoring in the reverse stock split

Yesterday, following unanimous approval of a 1:10 reverse stock split by the Board on 14th May, Avantium began trading on a post-reverse stock split basis. As a result of the reverse stock split, shareholders have been allotted one new ordinary share with a par value of EUR1.00 for every 10 existin

Maria Vara
  • Maria Vara

ONWARD: Expanding BCI clinical evidence with 5th implant milestone

This morning, ONWARD announced two additional successful implants of its ARC-BCI system in SCI patients, bringing the total to five as part of ongoing clinical feasibility studies. The latest cases involved a 48-year-old man (upper-limb SCI, injury in 2024) and a 37-year-old woman (lower-limb SCI,

Gregory Ramirez
  • Gregory Ramirez

LECTRA BUY | EUR45 Good resistance Chinese lockdowns; strong orde...

º Q2 results were slightly below expectations, but remained decent despite lockdowns in China New system orders hold up well thanks to automotive Company guidance for 2022 has been tightened toward its mid-point

Thibault Morel
  • Thibault Morel

HMS NETWORKS: HMS Networks 2Q22 results above expectations | CONVICTIO...

HMS NETWORKS - CONVICTION BUY | SEK500 HMS Networks 2Q22 results above expectations 2Q22 sales and new orders above expectations Positive surprise on 2Q22 profitability

Cedric Rossi
  • Cedric Rossi

HUGO BOSS: Successful execution and healthy geo mix lead to raised FY2...

HUGO BOSS - NEUTRAL | EUR68 vs. EUR64 Successful execution and healthy geo mix lead to raised FY22 guidance Strong sales and EBIT beat in Q2 driven by execution… … and low exposure to China’s lockdowns FY22 sales and EBIT guidance revised upwards and we increase our FY22-23 estimates by 7%

Clement Genelot
  • Clement Genelot

ROCHE BOBOIS: Q4 topping expectations with good H1 2022 prospects

ROCHE BOBOIS: Q4 topping expectations with good H1 2022 prospects

Victor Floc’h
  • Victor Floc’h

ONCODESIGN (CORPORATE, TP EUR15) | R&D collaboration signed with TiumB...

ONCODESIGN (CORPORATE, TP EUR15) | R&D collaboration signed with TiumBio in fibrosis

ResearchPool Subscriptions

Get the most out of your insights

Get in touch